BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1016589)

  • 1. [The coagulase test. I].
    Chiarini F; del Piano M; Nicosia R
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):353-60. PubMed ID: 1016589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
    Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
    J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis of Staphylococcus aureus infections].
    Cotar AI
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):69-77. PubMed ID: 20422921
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection.
    John JF
    Curr Opin Mol Ther; 2006 Oct; 8(5):455-60. PubMed ID: 17078388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of coagulase and/or pigmentation with the virulence of a capsule-lacking Staphylococcus aureus in iron-compromised mice.
    Salamah AA
    Microbiologica; 1992 Jan; 15(1):75-8. PubMed ID: 1556963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of defective strains of methicillin resistance Staphylococcus aureus that do not produce coagulase or CF].
    Garbacz K; Piechowicz L; Wiśniewska K; Galiński J
    Med Dosw Mikrobiol; 2002; 54(1):1-8. PubMed ID: 12185679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulases as determinants of protective immune responses against Staphylococcus aureus.
    McAdow M; DeDent AC; Emolo C; Cheng AG; Kreiswirth BN; Missiakas DM; Schneewind O
    Infect Immun; 2012 Oct; 80(10):3389-98. PubMed ID: 22825443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of coagulase negative staphylococci on skin-relation to cutaneous infection by Staphylococcus aureus: experimental animal infection].
    Ikeda M
    Nihon Hifuka Gakkai Zasshi; 1987 Dec; 97(14):1631-43. PubMed ID: 3452664
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization of mice with the fibronectin-binding protein and clumping factor from Staphylococcus aureus: antibody response and resistance against intraperitoneal infection.
    Espersen F; Clemmensen I
    Acta Pathol Microbiol Immunol Scand C; 1985 Apr; 93(2):53-8. PubMed ID: 3160215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of Fcgamma receptors on Staphylococcus aureus infection.
    Gjertsson I; Kleinau S; Tarkowski A
    Microb Pathog; 2002 Oct; 33(4):145-52. PubMed ID: 12385742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against a secreted product of Staphylococcus aureus trigger phagocytic killing.
    Thomer L; Emolo C; Thammavongsa V; Kim HK; McAdow ME; Yu W; Kieffer M; Schneewind O; Missiakas D
    J Exp Med; 2016 Mar; 213(3):293-301. PubMed ID: 26880578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine design.
    Nanra JS; Timofeyeva Y; Buitrago SM; Sellman BR; Dilts DA; Fink P; Nunez L; Hagen M; Matsuka YV; Mininni T; Zhu D; Pavliak V; Green BA; Jansen KU; Anderson AS
    Vaccine; 2009 May; 27(25-26):3276-80. PubMed ID: 19200819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neutralizing effects of hyperimmune antibodies against extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus.
    Shannon O; Uekotter A; Flock JI
    Scand J Immunol; 2006 Mar; 63(3):184-90. PubMed ID: 16499571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus coagulase R domain, a new evasion mechanism and vaccine target.
    Pozzi C; Bagnoli F; Rappuoli R
    J Exp Med; 2016 Mar; 213(3):292. PubMed ID: 26951364
    [No Abstract]   [Full Text] [Related]  

  • 15. Coagulase-negative methicillin-resistant Staphylococcus aureus.
    Bayston R
    J Hosp Infect; 2006 Jan; 62(1):127. PubMed ID: 16257093
    [No Abstract]   [Full Text] [Related]  

  • 16. Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.
    Hair PS; Ward MD; Semmes OJ; Foster TJ; Cunnion KM
    J Infect Dis; 2008 Jul; 198(1):125-33. PubMed ID: 18544012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus.
    Nour El-Din AN; Shkreta L; Talbot BG; Diarra MS; Lacasse P
    Vaccine; 2006 Mar; 24(12):1997-2006. PubMed ID: 16426711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of serum albumin on coagulase release from Staphylococcus aureus derived from bullous impetigo.
    Dekio S; Jidoi J
    J Dermatol; 1984 Jun; 11(3):233-5. PubMed ID: 6386912
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of the coagulase reaction on the leukotactic effect of Staphylococcus aureus in artificial body cavities of rabbits].
    Kitzrow D; Blobel H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):310-5. PubMed ID: 7136349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal capacity of plasma and granulocytes in small-for-dates newborns.
    Prokopowicz J; Ziobro J; Iwaszko-Krawczuk W
    Acta Paediatr Acad Sci Hung; 1975; 16(3-4):267-70. PubMed ID: 1224974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.